Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
MLECW
Upturn stock ratingUpturn stock rating

Moolec Science SA Warrant (MLECW)

Upturn stock ratingUpturn stock rating
$0.03
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

03/13/2025: MLECW (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type Stock
Historic Profit -73.81%
Avg. Invested days 28
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 03/13/2025

Key Highlights

Company Size ETF
Market Capitalization 0 USD
Price to earnings Ratio -
1Y Target Price -
Price to earnings Ratio -
1Y Target Price -
Volume (30-day avg) 8192
Beta -0.48
52 Weeks Range 0.01 - 0.17
Updated Date 02/26/2025
52 Weeks Range 0.01 - 0.17
Updated Date 02/26/2025
Dividends yield (FY) -
Basic EPS (TTM) -

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -140.33%
Operating Margin (TTM) -134.97%

Management Effectiveness

Return on Assets (TTM) -20.16%
Return on Equity (TTM) -104.72%

Valuation

Trailing PE -
Forward PE -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -
Shares Outstanding -
Shares Floating 7319859
Shares Outstanding -
Shares Floating 7319859
Percent Insiders -
Percent Institutions -

Analyst Ratings

Rating -
Target Price -
Buy -
Strong Buy -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Moolec Science SA Warrant

stock logo

Company Overview

overview logo History and Background

Moolec Science SA is a food technology company focusing on molecular farming. The warrant is related to their public listing and future stock purchasing rights.

business area logo Core Business Areas

  • Molecular Farming: Develops real animal proteins in plants, enhancing nutritional value and sustainability.
  • Ingredient Development: Creating innovative food ingredients using plant-based platforms.

leadership logo Leadership and Structure

Information on the leadership team and organizational structure is available in their public filings and on their website. Generally structured around scientific, operational and financial expertise.

Top Products and Market Share

overview logo Key Offerings

  • Soybean Seed Oil Rich in Bovine Protein: Developing a soybean variety enriched with bovine protein. Market share data is emerging as the product is still under development. Competitors are traditional animal protein producers and other plant-based protein companies like Beyond Meat (BYND) and Impossible Foods.
  • Pig Procollagen in Soybean: Using soybeans to produce pig procollagen. Competitors are companies that produce procollagen via conventional methods, and companies in the alternative protein space such as Ginkgo Bioworks (DNA).

Market Dynamics

industry overview logo Industry Overview

The food technology industry is rapidly growing, driven by increasing demand for sustainable and ethical food sources. Molecular farming is a novel approach within this landscape.

Positioning

Moolec Science is positioned as a pioneer in molecular farming, aiming to disrupt the traditional animal protein market with plant-based alternatives. Their competitive advantage lies in their patented technology and unique product offerings.

Total Addressable Market (TAM)

The TAM for alternative protein is projected to reach hundreds of billions of dollars in the coming years. Moolec aims to capture a significant share of this market by offering sustainable and cost-effective protein sources.

Upturn SWOT Analysis

Strengths

  • Innovative technology
  • Strong intellectual property
  • First-mover advantage in molecular farming
  • Potential for cost-effective protein production

Weaknesses

  • Technology is still under development
  • Limited commercialization experience
  • Regulatory hurdles
  • Market acceptance risk

Opportunities

  • Growing demand for sustainable protein
  • Partnerships with food companies
  • Expansion into new markets
  • Increasing investment in food technology

Threats

  • Competition from established protein producers
  • Regulatory changes
  • Technological disruptions
  • Consumer skepticism

Competitors and Market Share

competitor logo Key Competitors

  • BYND
  • IMMP
  • DNA
  • INGR

Competitive Landscape

Moolec's competitive advantage lies in its novel molecular farming approach, but it faces challenges from established protein producers and other alternative protein companies. The market share of MLECW is relatively small compared to BYND and INGR.

Major Acquisitions

Growth Trajectory and Initiatives

Historical Growth: Historical growth is limited due to the company's early stage. Future growth depends on successful product development, regulatory approvals, and market acceptance.

Future Projections: Future projections vary depending on analyst estimates, but are largely positive given the growing demand for sustainable protein.

Recent Initiatives: Recent initiatives include ongoing research and development efforts, partnerships with industry stakeholders, and preparations for commercial product launches.

Summary

Moolec Science SA is a high-risk, high-reward food technology company pioneering molecular farming. Its strength is in its innovative approach, but it faces challenges in technology development, regulation, and market acceptance. Successful commercialization could result in significant growth, but failures could lead to substantial losses. Investment should be carefully considered given the uncertain outcomes. Focus is needed on R&D and on regulatory hurdles.

Similar Companies

BYNDratingrating

Beyond Meat Inc

$3.07
Small-Cap Stock
0%
PASS

BYNDratingrating

Beyond Meat Inc

$3.07
Small-Cap Stock
0%
PASS

DNAratingrating

Ginkgo Bioworks Holdings

$5.66
Small-Cap Stock
0%
PASS

DNAratingrating

Ginkgo Bioworks Holdings

$5.66
Small-Cap Stock
0%
PASS

IMMPratingrating

Immutep Ltd ADR

$1.77
Small-Cap Stock
0%
PASS

IMMPratingrating

Immutep Ltd ADR

$1.77
Small-Cap Stock
0%
PASS

INGRratingrating

Ingredion Incorporated

$135.96
Mid-Cap Stock
0%
PASS

INGRratingrating

Ingredion Incorporated

$135.96
Mid-Cap Stock
0%
PASS

Sources and Disclaimers

Data Sources:

  • Company SEC filings
  • Industry reports
  • Analyst estimates
  • Company Press Releases

Disclaimers:

This analysis is for informational purposes only and does not constitute financial advice. Investment decisions should be based on individual research and consultation with a qualified financial advisor. Market share estimates are approximate and subject to change.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Moolec Science SA Warrant

Exchange NASDAQ
Headquaters -
IPO Launch date 2023-01-03
Co-Founder, CEO & Director Mr. Gaston Paladini M.B.A.
Sector Healthcare
Industry Biotechnology
Full time employees 52
Full time employees 52

Moolec Science SA, a science-based food ingredient company, focuses on developing ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology. It develops textured soy proteins, safflower oil, meat replacement products, food ingredients, and nutritional supplements. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg, Luxembourg.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​